The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
18795967
PubMed Central
PMC2680266
DOI
10.1111/j.1742-1241.2008.01903.x
PII: IJCP1903
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- hospitalizace statistika a číselné údaje MeSH
- lékařská informatika metody MeSH
- lidé MeSH
- následné studie MeSH
- schizofrenie prevence a kontrola MeSH
- sekundární prevence MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
AIMS: Decreasing a number of hospital admissions is important for improving outcomes for people with schizophrenia. The Information Technology Aided Relapse Prevention Programme in Schizophrenia (ITAREPS) programme enables early pharmacological intervention in psychosis by identification of prodromal symptoms of relapse using home telemonitoring via a phone-to-PC SMS platform. METHODS: This study was a 1-year extension of a previously published mirror-design follow-up evaluation of programme clinical effectiveness. In total, 73 patients with psychotic illness (45 patients from original sample and 28 newly added subjects) collaborating with 56 family members participated in the clinical evaluation. RESULTS: There was a statistically significant 77% decrease in the number of hospitalisations during the mean 396.8 +/- 249.4 days of participation in ITAREPS, compared with the same time period before participation in ITAREPS (Wilcoxon-signed ranks test, p < 0.00001), as well as significantly reduced number of hospitalisation days when in the ITAREPS (2365 hospitalisation days before and 991 days after ITAREPS enrolment respectively, Wilcoxon-signed ranks test, p < 0.003). CONCLUSION: The ITAREPS programme represents an effective tool in the long-term treatment of patients with psychotic disorders.
Zobrazit více v PubMed
McGlashan T. Is active psychosis neurotoxic? Schizophr Bull. 2006;32:609–13. PubMed PMC
Shepherd M, Watt D, Falloon I, Smeeton N. The natural-history of schizophrenia – a 5-year follow-up-study of outcome and prediction in a representative sample of schizophrenics. Psychol Med Monogr Suppl. 1989;15:1–46. PubMed
Wiersma D, Nienhuis F, Slooff C, Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull. 1998;24:75–85. PubMed
Lieberman J, Koreen A, Chakos M, et al. Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry. 1996;57:5–9. PubMed
Van Haren N, Hulshoff Pol H, Schnack H, et al. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology. 2007;32:2057–66. PubMed
Perkins D, Gu H, Boteva K, Lieberman J. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005;162:1785–804. PubMed
Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62:975–83. PubMed
Španiel F, Vohlídka P, Hrdlička J, et al. ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophr Res. 2008;98:312–7. PubMed
Španiel F, Novák T, Motlová L, Hrdlička J, Höschl C. Information technology aided relapse prevention program in schizophrenia (ITAREPS): reliability and validity of the early warning signs questionnaire. Psychiatry. 2007;11:157–9.
Herz M, Lamberti J, Mintz J, et al. A program for relapse prevention in schizophrenia – a controlled study. Arch Gen Psychiatry. 2000;57:277–83. PubMed
